Biography
Biography: Awatif Al Bahar
Abstract
Cervical cancer is the third most common cancer in females worldwide, with an estimated 530,000 cases in 2008.Approximately 85% of the global burden occurs in developing regions. Worldwide HPV causes-5% of all new cancers occurring in males & females annually .Approximately 80% of all people are infected by ≥ type of HPV at some point in their life time. Globally HPV is responsible for- >Virtually 100%of cervical cancer >88% of anal cancers >70% of vaginal cancers >43% of vulvar cancers >50% of penile cancers >26% of oropharyngeal cancers >Almost all cases of genital warts and RRP Benefits of adding males to current female HPV Vaccination- >Both males & females suffer a substantial burden of HPV-related cancers and diseases >HPV-related disease incidence is increasing in both genders >HPV is readily transmitted between males & females >No standardized screening programs, except for cervical cancer, to detect HPV-related cancers in males and females >Only HPV Vaccine licensed for use in males. More details will be discuss during the lecture